Galantamine

Generic name: Pronounced as (ga lan' ta meen)
Brand names
  • Razadyne® (formerly available as Reminyl®)
  • Razadyne® ER
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2020

Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future.

Galantamine comes as a tablet, an extended-release (long-acting) capsule, and a solution (liquid) to take by mouth. The tablets and liquid are usually taken twice a day, preferably with the morning and evening meals. The extended-release capsules are usually taken once a day in the morning. Take galantamine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take galantamine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. You are less likely to experience side effects of galantamine if you follow the exact dosing schedule prescribed by your doctor.

Swallow the extended-release capsules whole; do not crush or chew them.

Galantamine may upset your stomach, especially at the beginning of your treatment. Take galantamine with food and drink 6 to 8 glasses of water every day. This may decrease the chance that you will have an upset stomach during your treatment.

Your doctor will probably start you on a low dose of galantamine and gradually increase your dose, not more often than once every 4 weeks.

Continue to take galantamine even if you feel well. Do not stop taking galantamine without talking to your doctor. If you do stop taking galantamine for a few days or longer, call your doctor before you start to take galantamine again. Your doctor will probably tell you to start with the lowest dose of galantamine and gradually increase your dose to the dose you had been taking.

Before you take galantamine oral solution for the first time, read the written instructions that come with it. Ask your doctor or pharmacist to show you how to take the oral solution. To take the oral solution, follow these steps:

  1. Open the child-proof cap by pushing the cap down while turning it to the left. Remove the cap.

  2. Pull the pipette (the tube that you use to measure the dose of galantamine) out of its case.

  3. Place the pipette fully into the bottle of galantamine.

  4. While holding the bottom ring of the pipette, pull the pipette plunger up to the marking that shows the dose your doctor prescribed.

  5. Hold the bottom ring of the pipette and remove the pipette from the bottle. Be careful not to push the plunger in.

  6. Prepare 3 to 4 ounces (about 1/2 cup [90 to 120 milliliters]) of any non-alcoholic beverage. Empty all the medicine from the pipette into the beverage by pushing the plunger all the way in.

  7. Stir the beverage well.

  8. Drink all of the mixture right away.

  9. Put the plastic cap back on the bottle of galantamine and turn the cap to the right to close the bottle.

  10. Rinse the empty pipette by putting its open end into a glass of water, pulling the plunger out, and pushing the plunger in to remove the water.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking galantamine,

  • tell your doctor and pharmacist if you are allergic to galantamine, any other medications, or any of the inactive ingredients in galantamine tablets, solution, or extended-release capsules. Ask your pharmacist for a list of the inactive ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: ambenonium chloride (Mytelase); amitriptyline (Elavil); anticholinergic medications such as atropine (Atropen, Sal-Tropine), belladonna (in Donnatal, Bellamine, Bel-Tabs, others); benztropine (Cogentin), biperiden (Akineton); clidinium (in Librax), dicyclomine (Bentyl), glycopyrrolate (Robinul), hyoscyamine (Cytospaz-M, Levbid, Levsin), ipratropium (Atrovent, in Combivent), oxybutynin (Ditropan), procyclidine (Kemadrin), propantheline (Pro-Banthine), scopolamine (Scopace, Transderm-Scop), tiotropium (Spiriva), tolterodine (Detrol), and trihexyphenidyl; certain antifungals such as fluconazole (Diflucan), itraconazole (Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); bethanechol (Urecholine);cevimeline (Evoxac); cimetidine (Tagamet); clarithromycin (Biaxin, in Prevpac); digoxin (Lanoxin); fluoxetine (Prozac, Sarafem); fluvoxamine (Luvox); heart medications; nefazodone; neostigmine (Prostigmin);other medications for Alzheimer's disease; medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS); medications for high blood pressure; paroxetine (Paxil); pyridostigmine (Mestinon); and quinidine (Quinidex). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma or any other lung disease; an enlarged prostate; ulcers; seizures; irregular heartbeat; or heart, kidney, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking galantamine, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking galantamine.

  • you should know that galantamine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Galantamine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • diarrhea

    • loss of appetite

    • stomach pain

    • heartburn

    • weight loss

    • extreme tiredness

    • dizziness

    • pale skin

    • headache

    • shaking of a part of your body that you cannot control

    • depression

    • difficulty falling asleep or staying asleep

    • runny nose

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

    • difficulty urinating

    • blood in the urine

    • pain or burning while urinating

    • seizures

    • slowed heartbeat

    • fainting

    • shortness of breath

    • black and tarry stools

    • red blood in the stools

    • bloody vomit

    • vomit that looks like coffee grounds

  • Galantamine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not freeze.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • muscle weakness or twitching

  • nausea

  • vomiting

  • stomach cramps

  • drooling

  • teary eyes

  • increased urination

  • need to have a bowel movement

  • sweating

  • slowed, fast, or irregular heartbeat

  • lightheadedness

  • dizziness

  • fainting

  • slowed breathing

  • collapse

  • loss of consciousness

  • seizures

  • dry mouth

  • chest pain

  • hallucinations (seeing things or hearing voices that do not exist)

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Moxifloxacin.
Delavirdine Delavirdine The metabolism of Galantamine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Galantamine can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dolasetron.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Anagrelide.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cilostazol.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Galantamine is combined with Erythromycin.
Guanfacine Guanfacine Galantamine may increase the bradycardic activities of Guanfacine.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Galantamine is combined with Acebutolol.
Prednisone Prednisone The therapeutic efficacy of Galantamine can be decreased when used in combination with Prednisone.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Galantamine.
Tacrolimus Tacrolimus The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tacrolimus.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tizanidine.
Triamcinolone Triamcinolone The therapeutic efficacy of Galantamine can be decreased when used in combination with Triamcinolone.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Galantamine.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Galantamine.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Galantamine can be decreased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The therapeutic efficacy of Galantamine can be decreased when used in combination with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The metabolism of Galantamine can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Metronidazole.
Altretamine Altretamine The metabolism of Galantamine can be decreased when combined with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Galantamine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Galantamine is combined with Granisetron.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Olanzapine.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dofetilide.
Entacapone Entacapone The metabolism of Galantamine can be decreased when combined with Entacapone.
Hydroxychloroquine Hydroxychloroquine The metabolism of Galantamine can be decreased when combined with Hydroxychloroquine.
Anakinra Anakinra The metabolism of Galantamine can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Desloratadine.
Rivastigmine Rivastigmine Galantamine may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Galantamine.
Etanercept Injection Etanercept Injection The metabolism of Galantamine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.
Escitalopram Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Galantamine.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Galantamine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Galantamine is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Galantamine.
Atazanavir Atazanavir The risk or severity of QTc prolongation can be increased when Galantamine is combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Galantamine.
Eletriptan Eletriptan The metabolism of Galantamine can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Galantamine.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vardenafil.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Galantamine.
Tegaserod Tegaserod The metabolism of Galantamine can be decreased when combined with Tegaserod.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Galantamine can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Galantamine can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Galantamine.
Duloxetine Duloxetine The metabolism of Galantamine can be decreased when combined with Duloxetine.
Trospium Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.
Cinacalcet Cinacalcet The metabolism of Galantamine can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Galantamine.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Solifenacin.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Galantamine.
Dextroamphetamine Dextroamphetamine The metabolism of Galantamine can be decreased when combined with Amphetamine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Galantamine can be decreased when combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ibandronate.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Galantamine.
Fentanyl Fentanyl Galantamine may increase the bradycardic activities of Fentanyl.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Galantamine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Galantamine.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Galantamine is combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Galantamine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Galantamine can be increased when combined with Abatacept.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Imatinib.
Varenicline Varenicline The risk or severity of adverse effects can be increased when Galantamine is combined with Varenicline.
Gefitinib Gefitinib The metabolism of Galantamine can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Galantamine is combined with Salbutamol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Galantamine is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Galantamine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Galantamine is combined with Posaconazole.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Galantamine.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The metabolism of Galantamine can be decreased when combined with Lisdexamfetamine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Galantamine.
Sunitinib Sunitinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sunitinib.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levocetirizine.
Dasatinib Dasatinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Galantamine can be decreased when combined with Mexiletine.
Temsirolimus Temsirolimus The metabolism of Galantamine can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Galantamine.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Galantamine is combined with Toremifene.
Budesonide Budesonide The therapeutic efficacy of Galantamine can be decreased when used in combination with Budesonide.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The metabolism of Galantamine can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Galantamine can be decreased when combined with Cevimeline.
Nebivolol Nebivolol Galantamine may increase the bradycardic activities of Nebivolol.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Galantamine is combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Galantamine.
Certolizumab Injection Certolizumab Injection The metabolism of Certolizumab pegol can be increased when combined with Galantamine.
Irinotecan Injection Irinotecan Injection Galantamine may increase the neuromuscular blocking activities of Irinotecan.
Fesoterodine Fesoterodine The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Galantamine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Galantamine is combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Galantamine is combined with Iloperidone.
Lacosamide Lacosamide Galantamine may increase the bradycardic activities of Lacosamide.
Everolimus Everolimus The metabolism of Galantamine can be decreased when combined with Everolimus.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Galantamine.
Palonosetron Injection Palonosetron Injection The metabolism of Galantamine can be decreased when combined with Palonosetron.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Galantamine can be decreased when combined with Tapentadol.
Golimumab Injection Golimumab Injection The metabolism of Galantamine can be increased when combined with Golimumab.
Pazopanib Pazopanib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Pazopanib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Asenapine.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Galantamine.
Tocilizumab Injection Tocilizumab Injection The metabolism of Galantamine can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Galantamine may increase the bradycardic activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Eribulin.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Galantamine can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Galantamine can be decreased when combined with Vilazodone.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Terbutaline.
Rilpivirine Rilpivirine The metabolism of Galantamine can be decreased when combined with Rilpivirine.
Abiraterone Abiraterone The metabolism of Galantamine can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Triptorelin.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Galantamine.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vandetanib.
Clobazam Clobazam The metabolism of Galantamine can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vemurafenib.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Crizotinib.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Galantamine.
Regorafenib Regorafenib Galantamine may increase the bradycardic activities of Regorafenib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The therapeutic efficacy of Galantamine can be decreased when used in combination with Corticotropin.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Galantamine is combined with Bedaquiline.
Tofacitinib Tofacitinib Galantamine may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Galantamine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Galantamine.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Galantamine can be decreased when combined with Ospemifene.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Galantamine.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Galantamine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Galantamine.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Galantamine.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Galantamine.
Ceritinib Ceritinib Galantamine may increase the bradycardic activities of Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Galantamine can be increased when combined with Siltuximab.
Oritavancin Injection Oritavancin Injection The metabolism of Galantamine can be decreased when combined with Oritavancin.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Galantamine.
Lanreotide Injection Lanreotide Injection Galantamine may increase the bradycardic activities of Lanreotide.
Secukinumab Injection Secukinumab Injection The metabolism of Galantamine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Risperidone.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Galantamine can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Galantamine can be decreased when combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Haloperidol.
Ivabradine Ivabradine Galantamine may increase the bradycardic activities of Ivabradine.
Rolapitant Rolapitant The metabolism of Galantamine can be decreased when combined with Rolapitant.
Prednisolone Prednisolone The therapeutic efficacy of Galantamine can be decreased when used in combination with Prednisolone.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Galantamine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Galantamine.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Galantamine.
Dexamethasone Injection Dexamethasone Injection The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone.
Cobicistat Cobicistat The metabolism of Galantamine can be decreased when combined with Cobicistat.
Midodrine Midodrine Midodrine may increase the bradycardic activities of Galantamine.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Diphenhydramine.
Rucaparib Rucaparib The metabolism of Galantamine can be decreased when combined with Rucaparib.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Doxepin is combined with Galantamine.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Galantamine.
Deflazacort Deflazacort The therapeutic efficacy of Galantamine can be decreased when used in combination with Deflazacort.
Safinamide Safinamide The metabolism of Galantamine can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Galantamine can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Galantamine can be decreased when combined with Enasidenib.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Delafloxacin.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Galantamine.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tetrabenazine.
Buprenorphine Injection Buprenorphine Injection The metabolism of Galantamine can be decreased when combined with Buprenorphine.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lofexidine.
Eliglustat Eliglustat The metabolism of Galantamine can be decreased when combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Galantamine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Galantamine.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Galantamine.
Dacomitinib Dacomitinib The metabolism of Galantamine can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Galantamine can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Glasdegib.
Rifamycin Rifamycin The metabolism of Galantamine can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Galantamine can be increased when combined with Emapalumab.
Triclabendazole Triclabendazole The metabolism of Galantamine can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Galantamine is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Galantamine.
Pitolisant Pitolisant The serum concentration of Galantamine can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Galantamine can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Galantamine.
Phenytoin Injection Phenytoin Injection The metabolism of Galantamine can be decreased when combined with Phenytoin.
Lasmiditan Lasmiditan Lasmiditan may increase the bradycardic activities of Galantamine.
Cenobamate Cenobamate The serum concentration of Galantamine can be decreased when it is combined with Cenobamate.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Galantamine.
Fenfluramine Fenfluramine The metabolism of Galantamine can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of the active metabolites of Galantamine can be increased when Galantamine is used in combination with Octreotide.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Galantamine can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Galantamine is combined with Relugolix.
Theophylline Theophylline The metabolism of Galantamine can be decreased when combined with Theophylline.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Galantamine.
Hydroxyurea Hydroxyurea The metabolism of Galantamine can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Galantamine.
Primidone Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Galantamine.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Methsuximide.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Galantamine.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Amantadine.
Codeine Codeine The metabolism of Galantamine can be decreased when combined with Codeine.
Tranylcypromine Tranylcypromine The metabolism of Galantamine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Phenelzine can be decreased when combined with Galantamine.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Galantamine can be decreased when combined with Thioridazine.
Oxycodone Oxycodone The metabolism of Galantamine can be decreased when combined with Oxycodone.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Galantamine is combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Galantamine.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Benzatropine.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Galantamine is combined with Maprotiline.
Trihexyphenidyl Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.
Orphenadrine Orphenadrine The metabolism of Orphenadrine can be decreased when combined with Galantamine.
Perphenazine Perphenazine The metabolism of Galantamine can be decreased when combined with Perphenazine.
Fluphenazine Fluphenazine The metabolism of Galantamine can be decreased when combined with Fluphenazine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Galantamine.
Hydrocortisone Hydrocortisone The therapeutic efficacy of Galantamine can be decreased when used in combination with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Galantamine can be decreased when combined with Doxorubicin.
Methyldopa Methyldopa Galantamine may increase the bradycardic activities of Methyldopa.
Clonidine Clonidine The metabolism of Galantamine can be decreased when combined with Clonidine.
Cimetidine Cimetidine The metabolism of Galantamine can be decreased when combined with Cimetidine.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Promethazine.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Galantamine.
Chloroquine Chloroquine The metabolism of Galantamine can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Galantamine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Galantamine.
Secobarbital Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Galantamine.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Galantamine.
Amitriptyline Amitriptyline The metabolism of Galantamine can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Galantamine.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Galantamine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Galantamine.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Galantamine is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Galantamine can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Galantamine.
Methimazole Methimazole The metabolism of Galantamine can be decreased when combined with Methimazole.
Dextromethorphan Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Galantamine.
Niacin Niacin The metabolism of Galantamine can be decreased when combined with Niacin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Doxylamine.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cyproheptadine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Galantamine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Galantamine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone The metabolism of Galantamine can be decreased when combined with Chlorzoxazone.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Galantamine is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Galantamine is combined with Propranolol.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Galantamine.
Nadolol Nadolol Galantamine may increase the bradycardic activities of Nadolol.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Galantamine.
Flavoxate Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Galantamine.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fluorouracil.
Ketoconazole Ketoconazole The metabolism of Galantamine can be decreased when combined with Ketoconazole.
Dipyridamole Dipyridamole The therapeutic efficacy of Galantamine can be decreased when used in combination with Dipyridamole.
Vinblastine Vinblastine The metabolism of Galantamine can be decreased when combined with Vinblastine.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Galantamine is combined with Bethanechol.
Metoprolol Metoprolol The metabolism of Galantamine can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Galantamine.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Galantamine is combined with Thiothixene.
Dicyclomine Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Galantamine.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Hyoscyamine.
Propantheline Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Galantamine.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Galantamine is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Galantamine.
Verapamil Verapamil The metabolism of Galantamine can be decreased when combined with Verapamil.
Atenolol Atenolol Galantamine may increase the bradycardic activities of Atenolol.
Pindolol Pindolol Galantamine may increase the bradycardic activities of Pindolol.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Galantamine is combined with Indapamide.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Pentamidine.
Labetalol Labetalol Labetalol may increase the bradycardic activities of Galantamine.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Galantamine is combined with Leuprolide.
Pimozide Pimozide The metabolism of Galantamine can be decreased when combined with Pimozide.
Amiodarone Amiodarone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Galantamine.
Buspirone Buspirone The metabolism of Galantamine can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Galantamine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ciprofloxacin.
Fluoxetine Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Galantamine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Nimodipine.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Galantamine.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Galantamine.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ofloxacin.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Clarithromycin.
Felodipine Felodipine The metabolism of Galantamine can be decreased when combined with Felodipine.
Simvastatin Simvastatin The metabolism of Galantamine can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Amlodipine may increase the bradycardic activities of Galantamine.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Galantamine is combined with Itraconazole.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Galantamine.
Bisoprolol Bisoprolol Bisoprolol may increase the bradycardic activities of Galantamine.
Zolpidem Zolpidem The metabolism of Galantamine can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The metabolism of Galantamine can be decreased when combined with Doxazosin.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Galantamine.
Omeprazole Omeprazole The metabolism of Galantamine can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Galantamine.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Galantamine.
Venlafaxine Venlafaxine The metabolism of Galantamine can be decreased when combined with Venlafaxine.
Fluvoxamine Fluvoxamine The metabolism of Galantamine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Galantamine can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lamotrigine.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Galantamine is combined with Losartan.
Tramadol Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Galantamine.
Vinorelbine Injection Vinorelbine Injection The metabolism of Galantamine can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Galantamine is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Galantamine can be decreased when combined with Lansoprazole.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Galantamine.
Bupropion Bupropion The metabolism of Galantamine can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Galantamine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The risk or severity of QTc prolongation can be increased when Galantamine is combined with Saquinavir.
Nisoldipine Nisoldipine Nisoldipine may increase the bradycardic activities of Galantamine.
Ritonavir Ritonavir The serum concentration of Galantamine can be increased when it is combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Galantamine.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Galantamine.
Donepezil Donepezil Galantamine may increase the bradycardic activities of Donepezil.
Nelfinavir Nelfinavir The metabolism of Galantamine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Galantamine is combined with Azithromycin.
Carvedilol Carvedilol Galantamine may increase the bradycardic activities of Carvedilol.
Selegiline Selegiline The metabolism of Galantamine can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Galantamine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Galantamine can be decreased when combined with Sertraline.
Propafenone Propafenone The metabolism of Galantamine can be decreased when combined with Propafenone.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Galantamine.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Galantamine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Galantamine.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Galantamine is combined with Citalopram.
Efavirenz Efavirenz The risk or severity of QTc prolongation can be increased when Galantamine is combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Galantamine can be decreased when combined with Sildenafil.
Celecoxib Celecoxib The metabolism of Galantamine can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Galantamine can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tolterodine.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Galantamine.
Rabeprazole Rabeprazole The metabolism of Galantamine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Galantamine can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists